<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01188200</url>
  </required_header>
  <id_info>
    <org_study_id>BK79</org_study_id>
    <nct_id>NCT01188200</nct_id>
  </id_info>
  <brief_title>Four-Hour Evaluation of a Medical Food in Subjects With Type 2 Diabetes</brief_title>
  <official_title>Four-Hour Evaluation of a Medical Food in Subjects With Type 2 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Nutrition</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to demonstrate the efficacy of a nutritional formula in patients
      with type 2 diabetes.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2009</start_date>
  <completion_date type="Actual">June 2010</completion_date>
  <primary_completion_date type="Actual">June 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The primary variable is glucose concentration</measure>
    <time_frame>0 to 240 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Additional measures of glucose concentration</measure>
    <time_frame>0 to 240 mins</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">168</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>Nutritional Formula #M979</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>nutritional formula</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Regular standard meal</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>standard meal</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Experimental nutritional formula #M979</intervention_name>
    <description>One two hundred and forty mL serving at test time, taken orally</description>
    <arm_group_label>Nutritional Formula #M979</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard food</intervention_name>
    <description>Standard meal prior to test time</description>
    <arm_group_label>Regular standard meal</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject has type 2 diabetes.

          2. Subject is over 18 years of age.

          3. Subject is a male, or a non-pregnant, non-lactating female.

          4. Subject's BMI is &gt; 20 kg/m2 and &lt; 40 kg/m2.

          5. Subject's HbA1c level is 6.5 - 11%.

          6. If on a chronic thyroid medication or hormone replacement therapy, subject has been on
             constant dosage for at least two months prior to Screening Visit.

          7. Subject's weight is stable for the past two months prior to Screening Visit.

        Exclusion Criteria:

          1. Subject uses exogenous insulin, Byetta or alpha-glucosidase inhibitor for glucose
             control.

          2. Subject has type 1 diabetes.

          3. Subject has history of diabetic ketoacidosis.

          4. Subject has the following: current infection ; has had inpatient surgery or received
             systemic corticosteroid treatment in the last 3 months; or antibiotics in the last 3
             weeks prior to screening.

          5. Subject has an active malignancy.

          6. Subject has had significant cardiovascular event &lt;6 months prior to study entry or
             history of congestive heart failure.

          7. Subject has end stage organ failure.

          8. Subject has history of severe gastroparesis, renal or hepatic disease.

          9. Subject has an active metabolic, hepatic, or gastrointestinal disease or condition
             that may interfere with nutrient absorption, distribution, metabolism, or excretion,
             excluding diabetes.

         10. Subject has a chronic, contagious, infectious disease.

         11. Taking daily medications at doses that would interfere with nutrient absorption,
             metabolism, excretion, gastric motility, or blood glucose.

         12. Subject has fainted or experienced other adverse event in response to blood collection
             prior to enrollment into this study.

         13. Clotting or bleeding disorders.

         14. Allergic or intolerant to any ingredient found in the test meal.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne Voss, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Abbott Nutrition</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kuban State Medical University</name>
      <address>
        <city>Krasnodar</city>
        <zip>350043</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City Clinical Hospital #68</name>
      <address>
        <city>Moscow</city>
        <zip>109263</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City Clinical Hospital #52</name>
      <address>
        <city>Moscow</city>
        <zip>123182</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City Hospital #67</name>
      <address>
        <city>Moscow</city>
        <zip>123423</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novosibirsk State Medical University</name>
      <address>
        <city>Novosibirsk</city>
        <zip>630047</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>State Novosibirsk Regional Hospital</name>
      <address>
        <city>Novosibirsk</city>
        <zip>630087</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diabetes Centre, LLC</name>
      <address>
        <city>Samara</city>
        <zip>443046</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Centre Twenty First Century</name>
      <address>
        <city>St. Petersburgh</city>
        <zip>190068</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City Clinical Hospital #3</name>
      <address>
        <city>St. Petersburg</city>
        <zip>195257</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tyumen State Medical Academy</name>
      <address>
        <city>Tyumen</city>
        <zip>625023</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bashkir State Medical University</name>
      <address>
        <city>Ufa</city>
        <zip>450071</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>July 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 24, 2010</study_first_submitted>
  <study_first_submitted_qc>August 24, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 25, 2010</study_first_posted>
  <last_update_submitted>August 24, 2010</last_update_submitted>
  <last_update_submitted_qc>August 24, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 25, 2010</last_update_posted>
  <responsible_party>
    <name_title>Bobbie Swearengin, Director Clinical Research</name_title>
    <organization>Abbott Nutrition</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

